| Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug | Frank Vinluan | 02/20/20 | San Francisco |
| Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
| IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator | Frank Vinluan | 12/02/19 | Boston |
| Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets | Frank Vinluan | 07/18/19 | San Francisco |
| It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help | Frank Vinluan | 04/18/19 | Boston |
| Gossamer Bio Files for IPO at End of Year in Which It Raised $330M | Sarah de Crescenzo | 12/24/18 | San Diego |
| Ligand Inks Deal, Ionis Details Succession Plan, & More SD Biotech | Sarah de Crescenzo | 12/21/18 | San Diego |
| Morphic Nets Another $80M For Integrin Drugs & First Human Tests | Ben Fidler | 09/25/18 | Boston |
| Prevail Gets $75M For Parkinson’s Gene Therapy, Bolstering NY Biotech | Ben Fidler | 03/08/18 | New York |
| Synthetic Bio Startup Senti Raises $53M to Program Cells to Treat Disease | Frank Vinluan | 02/27/18 | San Francisco |
| Morphic Therapeutic Garners $51,500,000 Series A Funding | VentureDeal | 06/30/16 | Boston |
| CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas | Ben Fidler | 08/10/15 | Boston |
| Editas Medicine Garners $120,000,000 New Funding | VentureDeal | 08/10/15 | Boston |
| RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B | Ben Fidler | 07/23/15 | Boston |
| RaNA Therapeutics Receives $55,000,000 Series B Funding Round | VentureDeal | 07/23/15 | Boston |
| XTuit Gets $22M From NEA, Polaris to Battle Cancer, Liver Disease | Ben Fidler | 06/11/15 | Boston |
| Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology | Ben Fidler | 04/23/15 | Boston |
| East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More | Ben Fidler | 10/06/14 | Boston |
| Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday | Ben Fidler | 01/29/14 | Boston |
| Visterra Adds $8M, Ex-Amag Execs, To Begin Clinical Push for Flu Antibody | Ben Fidler | 12/02/13 | Boston |
| Visterra Obtains $8,100,000 Series A Financing | VentureDeal | 12/02/13 | Boston |
| East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More | Ben Fidler | 08/02/13 | Boston |
| Dicerna Snags $60M as RNAi Heats Up Again | Ben Fidler | 08/01/13 | Boston |
| Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding | VentureDeal | 08/01/13 | Boston |
| Visterra Obtains $13,000,000 Series A Financing | VentureDeal | 11/09/12 | Boston |
